Enveric Biosciences, Inc.
ENVB
$1.69
$0.095.63%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.91M | 4.68M | 3.76M | 2.85M | 4.29M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 4.70K | 45.20K | 59.10K | 65.40K | -- |
| Prepaid Expenses | 456.20K | 165.80K | 311.10K | 389.00K | 540.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.50K | 48.20K | 37.70K | 3.20K | 400.00 |
| Total Current Assets | 5.38M | 4.94M | 4.17M | 3.31M | 4.83M |
|
|
|||||
| Total Current Assets | 5.38M | 4.94M | 4.17M | 3.31M | 4.83M |
| Net Property, Plant & Equipment | 119.90K | 159.20K | 196.50K | 241.10K | 267.30K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 26.40K | -- | -- | -- | -- |
| Total Assets | 5.52M | 5.10M | 4.36M | 3.55M | 5.10M |
|
|
|||||
| Total Accounts Payable | 280.30K | 581.00K | 683.70K | 1.04M | 669.20K |
| Total Accrued Expenses | 180.40K | 337.40K | 222.20K | 322.70K | 497.20K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 18.00K |
| Total Other Current Liabilities | -- | -- | -- | -- | 18.00K |
| Total Current Liabilities | 460.70K | 918.40K | 905.90K | 1.36M | 1.18M |
|
|
|||||
| Total Current Liabilities | 460.70K | 918.40K | 905.90K | 1.36M | 1.18M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 460.70K | 918.40K | 905.90K | 1.36M | 1.18M |
|
|
|||||
| Common Stock & APIC | 122.13M | 119.60M | 116.69M | 113.54M | 112.78M |
| Retained Earnings | -116.48M | -114.85M | -112.65M | -110.78M | -108.26M |
| Treasury Stock & Other | -587.10K | -580.00K | -580.90K | -573.50K | -598.00K |
| Total Common Equity | 5.06M | 4.18M | 3.46M | 2.18M | 3.92M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.06M | 4.18M | 3.46M | 2.18M | 3.92M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.06M | 4.18M | 3.46M | 2.18M | 3.92M |
|
|
|||||